Population Heterogeneity in the Genetic Control of Serum Urate

Seminars in Nephrology

Volumn 31, Issue 5, 2011, Pages 420-425

  Merriman, Tony R ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

ABCG2; Association; Gene; Gout; SLC2A9; Uric Acid

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CARRIER PROTEIN; GCKR PROTEIN; GENE PRODUCT; GLUT9 PROTEIN; SLC16A9 PROTEIN; SLC2A9 PROTEIN; SODIUM PHOSPHATE COTRANSPORTER 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URATE; URIC ACID;

ABCG2 GENE; AFRICAN AMERICAN; ALLELE; ARTICLE; ASIAN; CAUCASIAN; CHINESE; FOUNDER EFFECT; GCKR GENE; GENE; GENE FREQUENCY; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC REGULATION; GENETIC RISK; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; GLUT9 GENE; GOUT; HERITABILITY; HUMAN; HYPERURICEMIA; INHERITANCE; JAPANESE; NEW ZEALAND; NPT1 GENE; POLYNESIA; POPULATION GENETICS; POPULATION MIGRATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SLC16A9 GENE; SLC2A9 GENE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

CONTINENTAL POPULATION GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; GOUT; HUMANS; HYPERURICEMIA; URIC ACID;

EID: 80054084280     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2011.08.005     Document Type: Article

References (43)

1. Manolio T.A. Genomewide association studies and assessment of the risk of disease. N Engl J Med 2010, 363:166-176.
2. McKinney C., Merriman T.R. The human genome and understanding of common disease: current technologies. Cell Mol Life Sci 2007, 64:961-978.
3. Voight B.F., Scott L.J., Steinthorsdottir V., Morris A.P., Dina C., Welch R.P., et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010, 42:579-589.
4. Gibson T., Waterworth R., Hatfield P., Robinson G., Bremner K. Hyperuricaemia, gout and kidney function in New Zealand Māori men. Br J Rheumatol 1984, 23:276-282.
5. Simmonds H.A., McBride M.B., Hatfield P.J., Graham R., McCaskey J., Jackson M. Polynesian women are also at risk for hyperuricaemia and gout because of a genetic defect in renal urate handling. Br J Rheumatol 1994, 33:932-937.
6. Emmerson B.T., Nagel S.L., O'Connor J., Duffy D.L., Martin N.G. The genetics of renal excretion of urate in man. Ann Rheum Dis 1992, 51:375-377.
7. Wilk J.B., Djousse L., Borecki I., Atwood L.D., Hunt S.C., Rich S.S., et al. Segregation analysis of serum uric acid in the NHLBI Family Heart Study. Hum Genet 2000, 106:355-359.
8. Li S., Sanna S., Maschio A Busonero F., Usala G., Mulas A., et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet 2007, 3:e194.
9. Vitart V., Rudan I., Hayward C., Gray N.K., Floyd J., Palmer C.N., et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 2008, 40:437-442.
10. Döring A., Gieger C., Mehta D., Gohlke H., Prokisch H., Coassin S., et al. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet 2008, 40:430-436.
11. Wallace C., Newhouse S.J., Braund P., Zhang F., Tobin M., Falchi M., et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet 2008, 82:139-149.
12. McArdle P.F., Parsa A., Chang Y.P., Weir M.R., O'Connell J.R., Mitchell B.D., et al. Association of a common nonsynonymous variant in GLUT9 with serum uric acid levels in old order Amish. Arthritis Rheum 2008, 58:2874-2881.
13. Dehghan A., Köttgen A., Yang Q., Hwang S.J., Kao W.L., Rivadeneira F., et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide study. Lancet 2008, 372:1953-1961.
14. Takanaga H., Chaudhuri B., Frommer W.B. GLUT1 and GLUT9 as major contributors to glucose influx in HepG2 cells identified by a high sensitivity intramolecular FRET glucose sensor. Biochim Biophys Acta 2008, 1778:1091-1099.
15. Woodward O.M., Kottgen A., Coresh J., Boerwinkle E., Guggino W.B., Kottgen M. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci U S A 2009, 106:10338-10342.
16. Matsuo H., Takada T., Ichida K., Nakamura T., Nakayama A., Ikebuchi Y., et al. Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci Translational Med 2010, 1. 5ra11.
17. Kondo C., Suzuki H., Itoda M., Ozawa S., Sawada J.D., Kobayashi D., et al. Functional analysis of SNPs variants of BCRP/ABCG2. Pharm Res 2004, 21:1895-1903.
18. Kolz M., Johnson T., Sanna S., Teumer A., Vitart V., Perola M., et al. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLos Genet 2009, 5:e1000504.
19. Graessler J., Graessler A., Unger S., Kopprasch S., Tausche A.K., Kuhlisch E., et al. Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population. Arthritis Rheum 2006, 54:292-300.
20. Shima Y., Teruya K., Ohta H. Association between intronic SNP in urate-anion exchanger gene, SLC22A12, and serum uric acid levels in Japanese. Life Sci 2006, 79:2234-2237.
21. van der Harst P., Bakker S.J., de Boer R.A., Wolffenbuttel B.H., Johnson T., Caulfield M.J., et al. Replication of the 5 novel loci for uric acid concentrations and potential mediating mechanisms. Hum Mol Genet 2010, 19:387-395.
22. Campion E.W., Glynn R.J., DeLabry L.O. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med 1987, 82:421-426.
23. Wallace S.L., Robinson H., Masi A.T., Decker J.L., McCarty D.J., Yu T.F. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977, 20:895-900.
24. Hollis-Moffatt J.E., Xu X., Dalbeth N., Merriman M.E., Topless R., Waddell C., et al. A role for the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island and Caucasian case-control cohorts. Arthritis Rheum 2009, 60:3485-3492.
25. Harrold L.R., Saag K.G., Yood R.A., Mikuls T.R., Andrade S.E., Fouayzi H., et al. Validity of gout diagnoses in administrative data. Arthritis Rheum 2007, 57:103-108.
26. Taylor W. Diagnosis of gout: considering clinical and research setting. Curr Rheum Rev 2011, 19:4813-9.
27. Jung J., Kang H., Cho Y.S., Oh J.H., Ryu M.H., Chung H.W., et al. Gene flow between the Korean peninsula and its neighboring countries. PLoS One 2010, 5:e11855.
28. Addison D.J., Matisoo-Smith E. Rethinking Polynesians origins: a West-Polynesia Triple-I model. Archaeol Oceania 2010, 45:1-12.
29. Kayser M., Brauer S., Cordaux R., Casto A., Lao O. Melanesian and Asian origins of Polynesians: mtDNA and Y chromosome gradients across the Pacific. Mol Biol Evol 2006, 23:2234-2244.
30. Tu H.P., Chen C.J., Tovosia S., Ko A.M., Lee C.H., Ou T.T., et al. Associations of a nonsynonymous variant in SLC2A9 with gouty arthritis and uric acid levels in Han Chinese and Solomon Islanders. Ann Rheum Dis 2010, 69:887-890.
31. Urano W., Taniguchi A., Anzai N., Inoue E., Sekita C., Endou H., et al. Association between GLUT9 and gout in Japanese men. Ann Rheum Dis 2010, 69:932-933.
32. Hollis-Moffatt J.E., Phipps-Green A.J., Merriman M.E., Topless R., Gow P., Harrison A.A., et al. The SLC2A9 non-synonymous Arg265His variant, rs3733591, and gout in New Zealand Māori, Pacific Island and Caucasian sample sets. Arthritis Res Ther 2010, 13:R85.
33. Phipps-Green A.J., Hollis-Moffatt J.E., Dalbeth N., Merriman M.E., Topless R., Gow P.J., et al. A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Maori, case and control sample sets. Hum Mol Genet 2010, 19:4813-4819.
34. Wang B., Miao Z., Liu S., Wang J., Zhou S., Han L., et al. Genetic analysis of ABCG2 gene C421A polymorphism with gout disease in Chinese Han male population. Hum Genet 2010, 127:145-146.
35. Yamagishi K., Tanigawa T., Kitamura A., Köttgen A., Folsom A.R., Iso H., et al. The rs2231142 variant of the ABCG2 gene is associated with uric acid levels and gout among Japanese people. Rheumatology 2010, 49:1461-1465.
36. Coop G., Pickrell J.K., Novembre J., Kudaravilli S., Li J., Absher D., et al. The role of geography in human adaptation. PLoS Genet 2009, 5:e1000500.
37. Iharada M., Miyaji T., Fujimoto T., Hiasa M., Anzai N., Omote H., et al. Type 1 sodium-dependent phosphate transporter (SLC17A1 protein) is a Cl (-)-dependent urate exporter. J Biol Chem 2010, 285:26107-26113.
38. Urano W., Taniguchi A., Anzai N., Inoue E., Kanai Y., Yamanaka M., et al. Sodium-dependent phosphate cotransporter type 1 sequence polymorphisms in male patients with gout. Ann Rheum Dis 2010, 69:1232-1234.
39. Hollis-Moffatt J.E., Phipps-Green A.J., Merriman M.E., Topless R., Gow P., Harrison A.A., et al. Confirmation of association of the SLC17A1 urate transport gene with gout in New Zealand Māori, Pacific Island and Caucasian sample sets 2010. Intern Med J 2011, 41(S1):29-30.
40. Annemans L., Spaepen E., Gaskin M., Bonnemaire M., Malier V., Gilbert T., et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis 2008, 67:960-966.
41. Miao Z., Li C., Chen Y., Zhao S., Wang Y., Wang Z., et al. Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol 2008, 35:1859-1864.
42. Klemp P., Stansfield S.A., Castle B., Robertson M.C. Gout is on the increase in New Zealand. Ann Rheum Dis 1997, 56:22-26.
43. Winnard D., Kake T., Gow P., Barratt-Boyes C., Wall L., Hall D.-A., et al. Debunking the myths to provide 21st century management of gout. N Z Med J 2008, 121:1274.